Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04483505Phase 1Completed
Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.
Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
PrincipalinvestigatorStart date: 2020-11-25

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Centro Nacional de Investigaciones Oncológicas

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Luis Manso, MD

Hospital Universitario 12 de Octubre

Related
1 trials

Shared therapeutic areas:

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Apices Soluciones S.L.Bayer+2 more
Collaborated on 1 trial
Similarity Score24%

Ramón Colomer i Bosch

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Related
1 trials

Shared therapeutic areas:

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Apices Soluciones S.L.Bayer+2 more
Collaborated on 1 trial
Similarity Score24%

Fabrice ANDRE, MD

Gustave Roussy, Cancer Campus, Grand Paris

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic

Worked with same sponsors:

Pfizer
Similarity Score15%

Michelle Melisko, MD

University of California, San Francisco

Related
5 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Bushra Shirazi

Sindh Institute of Urology and Transplantation

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Nicola Fusco, MD

Istituto Europeo di Oncologia

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Takayuki Ueno, MD,PhD

Cancer Institute Hospital of JFCR, Department Director, Breast Surgical Oncology Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Pfizer
Similarity Score15%

Masakazu Toi, MD,PhD

Kyoto University, Professor of Breast Surgery Department

Related
1 trials

Shared therapeutic areas:

Hormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Pfizer
Similarity Score15%

Antonio Llombart-Cussac

Arnau de Vilanova Hospital, Valencia (Spain)

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Antonio Llombart

MedSIR

Related
2 trials

Shared therapeutic areas:

Breast Cancer Metastatic
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04483505Phase 1PrincipalInvestigator

Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Breast Cancer MetastaticHormone Receptor Positive Malignant Neoplasm of Breast
Completed

All 1 trials loaded